Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Michael L. Wang, Simon Rule, Peter Martin, Andre Goy, Rebecca Auer, Brad S. Kahl, Wojciech Jurczak, Ranjana H. Advani, Jorge E. Romaguera, Michael E. Williams, Jacqueline C. Barrientos, Ewa Chmielowska, John Radford, Stephan Stilgenbauer, Martin Dreyling, Wieslaw Wiktor Jedrzejczak, Peter Johnson, Stephen E. Spurgeon, Lei Li, Liang ZhangKate Newberry, Zhishuo Ou, Nancy Cheng, Bingliang Fang, Jesse McGreivy, Fong Clow, Joseph J. Buggy, Betty Y. Chang, Darrin M. Beaupre, Lori A. Kunkel, Kristie A. Blum

Research output: Contribution to journal › Article › peer-review

1347 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences